Connor, Clark & Lunn Investment Management (CC&L)
OM icon

Connor, Clark & Lunn Investment Management (CC&L)’s Outset Medical OM Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-23,023
Closed -$767K – 1592
2024
Q1 		$767K Buy
+23,023
New +$1.17M ﹤0.01% 969
2023
Q4 		– Sell
-1,075
Closed -$175K – 1511
2023
Q3 		$175K Buy
+1,075
New +$254K ﹤0.01% 1252

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s OM Position: Q2 2024 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Outset Medical (OM) in Q2 2024, closing a stake of 23,023 shares — an estimated $767K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in OM in Q3 2023 and held it in 2 quarters. The position peaked at $767K in Q1 2024. 122 funds tracked by Wall St. Rank hold OM as of Q2 2024.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Outset Medical position as of Q2 2024 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 23,023 Outset Medical shares in Q2 2024, an estimated $767K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Outset Medical in Q3 2023 and held it in 2 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Outset Medical position peaked at $767K in Q1 2024.
  • 122 funds tracked by Wall St. Rank held Outset Medical as of Q2 2024.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2024, filed 9 Aug 2024.